Lafayette, CA, United States of America

Jerry A Peterson


Average Co-Inventor Count = 2.8

ph-index = 8

Forward Citations = 305(Granted Patents)


Location History:

  • Oakland, CA (US) (1986)
  • Lafayette, CA (US) (1991 - 2005)
  • Walnut Creek, CA (US) (2005)
  • San Francisco, CA (US) (2001 - 2008)

Company Filing History:


Years Active: 1986-2008

Loading Chart...
20 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Jerry A. Peterson - Pioneering Advancements in Breast Cancer Diagnostics and Therapeutics

Introduction:

Jerry A. Peterson, a distinguished inventor hailing from Lafayette, CA in the U.S., has made significant contributions to the field of breast cancer diagnostics and therapeutics through his innovative patents and research endeavors. With a total of 20 patents to his name, Peterson's groundbreaking work has propelled advancements in the diagnosis and treatment of breast cancer.

Latest Patents:

Among his latest patents is the development of recombinant peptides derived from the Mc3 anti-BA46 antibody. These peptides exhibit specific binding to the human milk fat globule (HMFG) antigen, BA46, proving invaluable for diagnostic, prognostic, and therapeutic applications in breast cancer. Additionally, Peterson has pioneered methods for the humanization of antibodies, leading to the production of humanized Mc3 antibodies with retained high-affinity binding capabilities.

Career Highlights:

Throughout his illustrious career, Jerry A. Peterson has been associated with esteemed organizations such as the Cancer Research Fund of Contra Costa and the Cancer Research Institute of Contra Costa. His relentless pursuit of scientific excellence and commitment to innovation has resulted in numerous breakthroughs that have significantly impacted the field of oncology.

Collaborations:

Collaborating with accomplished peers such as Roberto L. Ceriani and David J. Larocca, Peterson has fostered a culture of collaboration and knowledge exchange. Together, they have synergized their expertise to drive forward research initiatives aimed at combating breast cancer and improving patient outcomes.

Conclusion:

In conclusion, Jerry A. Peterson stands as a beacon of innovation in the realm of breast cancer diagnostics and therapeutics. His pioneering work in developing novel peptides, humanized antibodies, and cutting-edge immunoassay kits has paved the way for enhanced diagnostic accuracy and tailored treatment strategies in the fight against breast cancer. Peterson's unwavering dedication to advancing medical science underscores his enduring legacy as a visionary inventor in the field of oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…